US Stock MarketDetailed Quotes
APLM Apollomics
- 0.372
- -0.025-6.23%
Close May 10 16:00 ET
- 0.372
- +0.000+0.03%
Post 19:14 ET
33.28MMarket Cap-192P/E (TTM)
0.418High0.361Low200.06KVolume0.402Open0.397Pre Close75.98KTurnover0.33%Turnover RatioLossP/E (Static)89.50MShares6.45052wk High0.81P/B22.50MFloat Cap0.36152wk Low--Dividend TTM60.49MShs Float49.000Historical High--Div YieldTTM14.35%Amplitude0.361Historical Low0.379Avg Price1Lot Size
About Apollomics Company
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Company Profile
SymbolAPLM
Company NameApollomics
Listing DateNov 26, 2021
Founded2015
CEODr. Guo-Liang Yu, PhD
MarketNASDAQ
Employees45
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 220
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Websitehttp://www.apollomicsinc.com
Company Executives
- Name
- Position
- Salary
- Dr. Guo-Liang Yu, PhD
- Chairman of the Board and Chief Executive Officer
- --
- Dr. Lijuan Jane Wang, PhD
- Chief Scientific Officer
- --
- Dr. Kin-Hung Peony Yu, M.D.
- Chief Medical Officer
- --
- Dr. Sanjeev Redkar, PhD
- President, Director and Principal Financial Officer
- --
- Wendy Hayes
- Director
- --
- Dr. Jonathan Jian Wang, PhD
- Director
- --
- Glenn S. Vraniak
- Independent Director
- --
- Dr. Kenneth C. Carter, PhD
- Independent Director
- --
- Dr. Hong-Jung Moses Chen, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg